The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6% during the forecast period.
Increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine are the major factors that have supported long term expansion of Global Oligonucleotide Synthesis Market.
Global Oligonucleotide Synthesis Market is segmented into product, application, end user and geography.
Product segment is segmented into oligonucleotide-based drugs, synthesized oligonucleotide, reagents and equipment.
Application segment is segmented into therapeutic applications, therapeutic applications by disease type, diagnostic application and research applications.
End user segment is segmented into hospitals, pharmaceuticals & biotechnology companies, diagnostic laboratories, contract research organizations and contact manufacturing organizations (CROS & COMS) and academic research institutes.
Geographically, Global Oligonucleotide Synthesis market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in Global Oligonucleotide Synthesis market are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).
|
Report feature |
Descriptions |
|---|---|
|
Market revenue in 2021 |
USD 6.3 billion |
|
Growth rate |
CAGR of 17.6% during the forecast period |
|
Historical data |
2018-2019 |
|
Forecast years |
2021-2028 |
|
Base year |
2020 |
|
Units considered |
Revenue in USD billion |
|
Report segmentation |
product, application, end user and geography |
|
Report attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional level scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country level scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies profiled |
Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US). |
|
Available customizations |
In addition to the market data for Global Oligonucleotide Synthesis market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)